Type 1 plasminogen deficiency
Other Names for this Disease
On this page
The treatment options available for type 1 plasminogen deficiency are few. However, some cases of ligneous conjunctivitis, the most common disease manifestation, have been successfully treated using a combination of surgery and plasminogen administration. Surgery alone to remove the eye growths can be a temporary fix; however, irritation secondary to surgery can result in recurrence. Other therapies that have been utilized with a varying degree of success include: corticosteroids, immunosuppressants (Cyclosporine), blood thinners (heparin), alpha-chymotrypsin (digestive enzyme), plasma infusion (white blood cells), and anti-virals.
Last updated: 6/16/2016
- Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Hemostasis and Thrombosis. Philadelphia: Lippincott Williams & Wilkins; 2005;
- Michael J. Ang, Konstantinos I. Papageorgiou, Shu-Hong Chang, Jocelyn Kohn, Helen Chokron Garneau, Robert A. Goldberg. Topical Plasminogen as Adjunctive Treatment in Recurrent Ligneous Conjunctivitis. Ophthal Plast Reconstr Surg. April 8, 2016; http://www.ncbi.nlm.nih.gov/pubmed/27065432.